Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bridgewater

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
The Lancet. Gastroenterology & Hepatology|June 9, 2020
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspectiveAisling Barry, Smith Apisarnthanarax, Grainne M O'Kane, et al.
JAMA Oncology|November 24, 2017
Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational StatusJulien Taieb, Hampig Raphael Kourie, Jean-François Emile, et al.
Hepatology (Baltimore, Md.)|March 31, 2023
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancersChanghoon Yoo, Milind M Javle, Helena Verdaguer Mata, et al.
Gut|September 28, 2023
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinomaSimon M Rushbrook, Timothy James Kendall, Yoh Zen, et al.
Gut|August 19, 2024
Guidelines Development Group for the British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinomaShahid A Khan, Simon M Rushbrook, Timothy James Kendall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAActSheela Rao, Francesco Sclafani, Cathy Eng, et al.
The Lancet Regional Health. Europe|May 19, 2025
Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
Gut|May 17, 2022
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directionsRocio I R Macias, Vincenzo Cardinale, Timothy J Kendall, et al.
The Lancet Regional Health. Europe|March 17, 2025
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across EuropeLorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
Nature Genetics|November 5, 2025
Epigenetically driven and early immune evasion in colorectal cancer evolutionEszter Lakatos, Vinaya Gunasri, Luis Zapata, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
The Lancet. Gastroenterology & Hepatology|June 9, 2020
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspectiveAisling Barry, Smith Apisarnthanarax, Grainne M O'Kane, et al.
JAMA Oncology|November 24, 2017
Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational StatusJulien Taieb, Hampig Raphael Kourie, Jean-François Emile, et al.
Hepatology (Baltimore, Md.)|March 31, 2023
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancersChanghoon Yoo, Milind M Javle, Helena Verdaguer Mata, et al.
Gut|September 28, 2023
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinomaSimon M Rushbrook, Timothy James Kendall, Yoh Zen, et al.
Gut|August 19, 2024
Guidelines Development Group for the British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinomaShahid A Khan, Simon M Rushbrook, Timothy James Kendall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAActSheela Rao, Francesco Sclafani, Cathy Eng, et al.
The Lancet Regional Health. Europe|May 19, 2025
Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
Gut|May 17, 2022
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directionsRocio I R Macias, Vincenzo Cardinale, Timothy J Kendall, et al.
The Lancet Regional Health. Europe|March 17, 2025
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across EuropeLorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
Nature Genetics|November 5, 2025
Epigenetically driven and early immune evasion in colorectal cancer evolutionEszter Lakatos, Vinaya Gunasri, Luis Zapata, et al.
Pageof 13